Users Coming Off Weight-Loss Medications Put On Weight Four Times Faster Compared to Those on Conventional Diets

A recent study suggests that patients who stop using blockbuster GLP-1 drugs like semaglutide or tirzepatide can put back on lost weight much more quickly than those who end traditional diet and exercise programs.

Published data in a leading health publication demonstrates that while overweight people often shed a large proportion of their body weight while on the medication, the mass is regained at an estimated rate of nearly a kilo each month upon discontinuation.

"Users using these drugs need to be aware of the danger of rapid weight regain when the medication is stopped," warns lead investigator Dr. Susan Jebb.

This pace of recovery suggests a return to pre-treatment mass within about 18 months.

Analyzing Treatments

The analysis, which reviewed dozens of trials involving thousands of participants, contrasted the results of GLP-1 agonists with older methods.

The team note that individuals who shed pounds through dieting typically see a more gradual weight regain—approximately 0.1 kg a month—after stopping.

The Reason for the Quick Regain

Experts suggest the mode of action of the jabs explains the heightened regain.

The injections mimic a natural hormone called glucagon-like peptide-1, which controls feelings of fullness.

"Long-term administration of the hormone levels several times higher than the body's typical production may cause the body to produce less of its own natural hormone, and could diminish sensitivity to its effects," said Dr. Adam Collins, a dietetics specialist.

"Discontinuation of this GLP-1 'fix' results in hunger is no longer kept in check, making overeating much more probable."

An Ongoing Issue?

Medical guidelines suggest the injections for people with weight-linked medical conditions, accompanied by recommended lifestyle changes.

Many experts say that, due to the significant potential of relapse, the therapy should be considered life-long.

This view is echoed by pharmaceutical companies, who say that the results "emphasize the chronic nature of obesity," akin to managing diseases like diabetes.

User Testimonies

People who have stopped the medication describe a intense return of appetite.

"It felt as if a trigger flipping and I was suddenly starving," described an individual.

This challenge is exacerbated if patients have not adopted sustainable dietary or behavioural changes during treatment.

Growing Interest

Survey data show that a significant number of people in the UK have used these injections in the past year, with demand remaining high.

• Use is more common among women compared to males.
• The middle-aged demographic shows the highest level of interest.
• A large proportion obtain the medications through private prescriptions rather than the NHS.

In conclusion, clinicians stress that while the jabs are effective agents for shedding pounds, they are not a permanent solution and long-term success relies on ongoing behavioural changes.